Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share (ZURA)
CUSIP: G9TY5A101
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Class A Ordinary Shares, par value $0.0001 per share
- Shares outstanding
- 108,236,654
- Total 13F shares
- 32,818,331
- Share change
- +18,003,867
- Total reported value
- $114,851,034
- Price per share
- $3.50
- Number of holders
- 55
- Value change
- +$63,732,200
- Number of buys
- 37
- Number of sells
- 15
Quarterly Holders Quick Answers
What is CUSIP G9TY5A101?
CUSIP G9TY5A101 identifies ZURA - Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP G9TY5A101:
Top shareholders of ZURA - Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BARCLAYS PLC |
3/4/5
13F
|
10%+ Owner · Company |
0.01%
from 13F
|
2,340,240
|
$24,349,729 | — | 09 Jan 2023 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.6%
|
2,850,000
|
$7,324,500 | — | 31 Mar 2024 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
2.5%
|
2,757,740
|
$7,087,392 | — | 31 Mar 2024 | |
| Deep Track Capital, LP |
13F
|
Company |
2.3%
|
2,523,000
|
$6,484,110 | — | 31 Mar 2024 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
1.5%
|
1,648,000
|
$4,235,360 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1%
|
1,094,617
|
$2,813,166 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.63%
|
681,420
|
$1,751,249 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.53%
|
575,092
|
$1,477,986 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.45%
|
487,125
|
$1,252,154 | — | 31 Mar 2024 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.42%
|
450,009
|
$1,156,523 | — | 31 Mar 2024 | |
| Michael Howell |
3/4/5
|
Chief Scientific Officer and Head of Translational Science |
—
mixed-class rows
|
529,904
mixed-class rows
|
$1,063,813 | — | 18 Jun 2024 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.3%
|
328,504
|
$844,255 | — | 31 Mar 2024 | |
| Christopher Cabell |
3/4/5
|
CMO & Head of R&D |
—
class O/S missing
|
162,060
|
$648,240 | — | 18 May 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.2%
|
214,748
|
$551,902 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.17%
|
183,242
|
$470,932 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.16%
|
172,717
|
$443,882 | — | 31 Mar 2024 | |
| RAYMOND JAMES & ASSOCIATES |
13F
|
Company |
0.1%
|
111,347
|
$286,162 | — | 31 Mar 2024 | |
| Atom Investors LP |
13F
|
Company |
0.09%
|
94,982
|
$244,104 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.05%
|
53,117
|
$136,511 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
40,697
|
$104,591 | — | 31 Mar 2024 | |
| Forefront Analytics, LLC |
13F
|
Company |
0.03%
|
34,038
|
$87,478 | — | 31 Mar 2024 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.04%
|
38,999
|
$85,611 | — | 31 Mar 2024 | |
| METEORA CAPITAL, LLC |
13F
|
Company |
0.03%
|
28,702
|
$73,764 | — | 31 Mar 2024 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.02%
|
25,090
|
$64,481 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.02%
|
23,657
|
$60,798 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
22,160
|
$56,952 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.02%
|
21,456
|
$55,142 | — | 31 Mar 2024 | |
| Calamos Advisors LLC |
13F
|
Company |
0.18%
|
200,000
|
$54,000 | — | 31 Mar 2024 | |
| OCCUDO QUANTITATIVE STRATEGIES LP |
13F
|
Company |
0.02%
|
19,042
|
$48,938 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
17,232
|
$44,286 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.01%
|
15,523
|
$39,885 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
14,354
|
$36,889 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.01%
|
11,500
|
$30,000 | — | 31 Mar 2024 | |
| Eisler Capital (US) LLC |
13F
|
Company |
0.09%
|
100,000
|
$27,000 | — | 31 Mar 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
8,547
|
$21,966 | — | 31 Mar 2024 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
8,396
|
$21,578 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
7,284
|
$18,720 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
6,102
|
$15,682 | — | 31 Mar 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
4,307
|
$11,069 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
3,195
|
$8,211 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0%
|
2,962
|
$7,612 | — | 31 Mar 2024 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0%
|
1,934
|
$4,970 | — | 31 Mar 2024 | |
| STRS OHIO |
13F
|
Company |
0%
|
1,500
|
$4,000 | — | 31 Mar 2024 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
626
|
$1,609 | — | 31 Mar 2024 | |
| AMALGAMATED BANK |
13F
|
Company |
0%
|
256
|
$1,000 | — | 31 Mar 2024 | |
| Impact Partnership Wealth, LLC |
13F
|
Company |
0%
|
6
|
$15 | — | 31 Mar 2024 | |
| Hana Immunotherapeutics LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
5,404,274
|
— | — | 20 Mar 2023 | |
| PFIZER INC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,970,022
|
— | — | 20 Mar 2023 | |
| Ewon Comfortech Co., Ltd. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,000,000
|
— | — | 20 Mar 2023 | |
| JATT Ventures, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
967,370
|
— | — | 10 Feb 2023 |
Institutional Holders of Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share (ZURA) as of Q2 2024
As of 30 Jun 2024,
Zura Bio Ltd - Class A Ordinary Shares, par value $0.0001 per share (ZURA) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
32,818,331 shares.
The largest 10 holders included
VR Adviser, LLC, SUVRETTA CAPITAL MANAGEMENT, LLC, GREAT POINT PARTNERS LLC, Deep Track Capital, LP, RA CAPITAL MANAGEMENT, L.P., ARMISTICE CAPITAL, LLC, Point72 Asset Management, L.P., BlackRock Inc., CITADEL ADVISORS LLC, and VANGUARD GROUP INC.
This page lists
55
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
43
Q2 2024 holders
55
Holder diff
12
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.